Catalio Capital Management, LP
Filing Date
Global Rank
#2,379
/ 8,232
▼ 34
Top Industry
Biotechnology
75.4%
3Y Alpha vs SPY
+7.7%
Period ended 2 months ago
Filed May 15, 2026 · 30d
6 quarters · since Dec 2024
Clone Performance
Feb 2025–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+34.2%
SPY
+23.4%
Annualised alpha
+7.6%
Max drawdown
−22.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
41 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
9.8%
+3.2 pts
Top 5
33.1%
+3.5 pts
Top 10
54.5%
+3.3 pts
HHI
428
Diversified+52
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $478,705,573 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | +754,725 | 897,709 | $5,000,239 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +688,247 | 850,797 | $17,824,197 | |
| ELDN | Eledon Pharmaceuticals, Inc. | +379,996 | 1,639,816 | $5,050,633 | |
| HTFL | Heartflow, Inc. | +289,731 | 403,588 | $9,819,296 | |
| TERN | Terns Pharmaceuticals, Inc. | +272,073 | 409,031 | $21,564,114 | |
| SLNO | Soleno Therapeutics Inc | +217,468 | 577,808 | $19,345,011 | |
| QURE | uniQure N.V. | +202,771 | 491,116 | $8,029,746 | |
| MLYS | Mineralys Therapeutics, Inc. | +107,192 | 439,041 | $11,893,620 | |
| IRON | Disc Medicine, Inc. | +12,551 | 122,978 | $7,863,213 | |
| ASND | Ascendis Pharma A/S | +9,846 | 129,111 | $29,531,559 | |
| NTRA | Natera, Inc. | +8,634 | 70,907 | $14,180,690 | |
| GPCR | Structure Therapeutics Inc. | +2,478 | 255,379 | $12,309,267 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
13 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | −866,230 | 580,024 | $3,021,925 | |
| PHAT | Phathom Pharmaceuticals, Inc. | −451,229 | 247,767 | $2,752,691 | |
| DYN | Dyne Therapeutics, Inc. | −236,761 | 282,954 | $5,129,956 | |
| BMY | Bristol Myers Squibb Co | −227,172 | 420,727 | $25,517,092 | |
| SUPN | Supernus Pharmaceuticals, Inc. | −195,446 | 62,019 | $3,205,762 | |
| SNDX | Syndax Pharmaceuticals Inc | −153,137 | 1,043,670 | $24,380,131 | |
| GILD | Gilead Sciences, Inc. | −125,407 | 163,905 | $22,843,439 | |
| ADPT | Adaptive Biotechnologies Corp | −98,411 | 722,784 | $10,032,241 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −93,264 | 560,308 | $47,021,047 | |
| BSX | Boston Scientific Corp | −61,110 | 299,318 | $18,782,204 | |
| ABVX | Abivax S.A. | −51,321 | 47,193 | $5,254,940 | |
| CYTK | Cytokinetics Inc | −42,880 | 215,501 | $14,203,670 | |
| EW | Edwards Lifesciences Corp | −42,441 | 144,607 | $11,580,128 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 432,014 | $32,081,359 | |
| DFTX | Definium Therapeutics, Inc. | 1,037,984 | $19,617,897 | |
| INCY | Incyte Corp | 182,101 | $17,139,346 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 891,933 | $13,048,979 | |
| MANE | Veradermics, Inc | 173,582 | $10,961,703 | |
| KALV | KalVista Pharmaceuticals, Inc. | 426,551 | $8,586,471 | |
| NAMS | NewAmsterdam Pharma Co N.V. | 83,554 | $2,674,563 | |
| TYRA | Tyra Biosciences, Inc. | 67,285 | $2,577,015 | |
| IMCR | Immunocore Holdings plc | 84,352 | $2,543,212 | |
| ATAI | AtaiBeckley Inc. | 196,858 | $696,877 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
13 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | 25,923 | $27,858,932 | |
| JNJ | Johnson & Johnson | 120,840 | $25,007,838 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 29,797 | $22,999,410 | |
| ISRG | Intuitive Surgical Inc | 27,209 | $15,410,089 | |
| ADMA | Adma Biologics, Inc. | 564,461 | $10,295,768 | |
| ACLX | Arcellx, Inc. | 156,109 | $10,178,306 | |
| OCUL | Ocular Therapeutix, Inc | 714,501 | $8,674,042 | |
| OLMA | Olema Pharmaceuticals, Inc. | 267,058 | $6,676,450 | |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | 410,700 | $5,141,964 | |
| GRAL | GRAIL, Inc. | 30,313 | $2,594,489 | |
| FULC | Fulcrum Therapeutics, Inc. | 201,301 | $2,276,714 | |
| BLLN | BillionToOne, Inc. | 25,505 | $2,087,329 | |
| PVLA | Palvella Therapeutics, Inc. | 10,452 | $1,094,010 | |
| No positions match the current search. | ||||
41 positions ·
$478,705,573 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Reduced | 560,308 | $47,021,047 | 9.82% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
NEW | 432,014 | $32,081,359 | 6.70% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 129,111 | $29,531,559 | 6.17% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Reduced | 420,727 | $25,517,092 | 5.33% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 1,043,670 | $24,380,131 | 5.09% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Reduced | 163,905 | $22,843,439 | 4.77% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
Added | 409,031 | $21,564,114 | 4.50% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 1,037,984 | $19,617,897 | 4.10% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
Added | 577,808 | $19,345,011 | 4.04% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Reduced | 299,318 | $18,782,204 | 3.92% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 850,797 | $17,824,197 | 3.72% | |
| INCY |
Incyte Corp
Healthcare
|
NEW | 182,101 | $17,139,346 | 3.58% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 215,501 | $14,203,670 | 2.97% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 70,907 | $14,180,690 | 2.96% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
NEW | 891,933 | $13,048,979 | 2.73% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 255,379 | $12,309,267 | 2.57% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 439,041 | $11,893,620 | 2.48% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 144,607 | $11,580,128 | 2.42% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 173,582 | $10,961,703 | 2.29% | |
| ADPT |
Adaptive Biotechnologies Corp
Healthcare
|
Reduced | 722,784 | $10,032,241 | 2.10% | |
| HTFL |
Heartflow, Inc.
Healthcare
|
Added | 403,588 | $9,819,296 | 2.05% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
NEW | 426,551 | $8,586,471 | 1.79% | |
| QURE |
uniQure N.V.
Healthcare
|
Added | 491,116 | $8,029,746 | 1.68% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 122,978 | $7,863,213 | 1.64% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 294,360 | $7,073,470 | 1.48% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 47,193 | $5,254,940 | 1.10% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Reduced | 282,954 | $5,129,956 | 1.07% | |
| ELDN |
Eledon Pharmaceuticals, Inc.
Healthcare
|
Added | 1,639,816 | $5,050,633 | 1.06% | |
| KPTI |
Karyopharm Therapeutics Inc.
Healthcare
|
Added | 897,709 | $5,000,239 | 1.04% | |
| SUPN |
Supernus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 62,019 | $3,205,762 | 0.67% | |
| TARA |
Protara Therapeutics, Inc.
Healthcare
|
Reduced | 580,024 | $3,021,925 | 0.63% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
Reduced | 247,767 | $2,752,691 | 0.58% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
NEW | 83,554 | $2,674,563 | 0.56% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
NEW | 67,285 | $2,577,015 | 0.54% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
NEW | 84,352 | $2,543,212 | 0.53% | |
| GUTS |
Fractyl Health, Inc.
Healthcare
|
Held | 5,491,866 | $2,515,274 | 0.53% | |
| HYPR |
Hyperfine, Inc.
Healthcare
|
Held | 1,320,041 | $1,425,644 | 0.30% | |
| MGX |
Metagenomi Therapeutics, Inc.
Healthcare
|
Held | 528,993 | $708,850 | 0.15% | |
| ATAI |
AtaiBeckley Inc.
Healthcare
|
NEW | 196,858 | $696,877 | 0.15% | |
| SNSE |
Sensei Biotherapeutics, Inc.
Healthcare
|
Held | 14,718 | $463,911 | 0.10% | |
| OM |
Outset Medical, Inc.
Healthcare
|
Held | 118,279 | $454,191 | 0.09% |